3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
23
Pancreatic Neoplasms
9
Colonic Neoplasms
8
Stomach Neoplasms
7
Esophageal Neoplasms
7
Rectal Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma Of Esophagus
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Cholangiocarcinoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Interventions
pembrolizumab
9
Cetuximab
5
Surveys and Questionnaires
4
Cisplatin
4
dostarlimab
2
abemaciclib
2
Standard of Care
2
Docetaxel
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
tipifarnib
1
ribociclib
1
repotrectinib
1
palbociclib
1
olaparib
1
nimotuzumab
1
monalizumab
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
ebselen
1
durvalumab
1
disitamab vedotin
1
avelumab
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Fluorouracil
×
30 days
×
Clear all
No trials found.